Clinical trials

  • pembrolizumab for Locally advanced cervical cancer (high-risk)
  • Mitomycin (formulation contains poloxamer 407 excipient) for Non-muscle invasive bladder cancer
  • Belimumab for Systemic lupus erythematosus | Lupus nephritis
  • SEMAGLUTIDE for Non-alcoholic steatohepatitis (NASH)
  • ADENO-ASSOCIATED VIRUS VECTOR SEROTYPE 8 CONTAINING THE HUMAN F9 GENE for Hemophilia B
  • FERUMOXTRAN-10 for Esophageal cancer
  • DESMOPRESSIN ACETATE TRIHYDRATE for Severe hyponatremia
  • SULFUR HEXAFLUORIDE for Fetal growth restriction
  • VALOCTOCOGENE ROXAPARVOVEC for Hemophilia A
  • Mirabegron for Healthy volunteers
  • DANTROLENE SODIUM for Glabellar lines
  • Clinical trial in Advanced solid tumour